A Meta-Analysis of Randomized Controlled Trials of Aspirin in Primary Prevention of Cardiovascular Disease.

被引：0
|
作者：
Raju, Nina C. [1 ]
Sobieraj-Teague, Magda [1 ]
Eikelboom, John W. [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [1] Aspirin for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
    De Berardis, Giorgia
    Sacco, Michele
    Graziano, Giusi
    Pellegrini, Fabio
    Nicolucci, Antonio
    DIABETES, 2009, 58 : A24 - A24
  • [2] Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis of randomized controlled trials
    Berwanger, Otavio
    Oliveira, Joao Bosco
    Suzumura, Erica
    Buhler, Anna M.
    Oliveira, Dinaldo
    Marx, Carlos B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A365 - A365
  • [3] Aspirin in primary prevention of cardiovascular events in women and men - (A meta-analysis of randomized controlled trials)
    Yavelov, I. S.
    KARDIOLOGIYA, 2006, 46 (03) : 75 - 76
  • [4] Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials
    Barbarawi, Mahmoud
    Kheiri, Babikir
    Zayed, Yazan
    Gakhal, Inderdeep
    Al-Abdouh, Ahmad
    Barbarawi, Owais
    Rashdan, Laith
    Rizk, Fatima
    Bachuwa, Ghassan
    Alkotob, Mohammad Luay
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2019, 26 (04) : 283 - 291
  • [5] Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials
    Mahmoud Barbarawi
    Babikir Kheiri
    Yazan Zayed
    Inderdeep Gakhal
    Ahmad Al-Abdouh
    Owais Barbarawi
    Laith Rashdan
    Fatima Rizk
    Ghassan Bachuwa
    Mohammad Luay Alkotob
    High Blood Pressure & Cardiovascular Prevention, 2019, 26 : 283 - 291
  • [6] Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
    Marit de Jong
    H. Bart van der Worp
    Yolanda van der Graaf
    Frank L. J. Visseren
    Jan Westerink
    Cardiovascular Diabetology, 16
  • [7] Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
    de Jong, Marit
    van der Worp, H. Bart
    van der Graaf, Yolanda
    Visseren, Frank L. J.
    Westerink, Jan
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [8] ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Alrifai, A.
    Al Halabi, S.
    Rosenstein, R. S.
    CARDIOLOGY, 2015, 131 : 93 - 93
  • [9] ASPIRIN FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: AN UPDATED META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Shah, Rahman
    Rawal, Aranyak
    Najib, Khalid
    Khan, Babar
    Hesterberg, Kirstin
    Rashid, Abdul
    Latham, Samuel B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1782 - 1782
  • [10] Aspirin for primary prevention of cardiovascular disease: a meta-analysis
    Gelbenegger, Georg
    Postula, Marek
    Pecen, Ladislav
    Halvorsen, Sigrun
    Lesiak, Maciej
    Schoergenhofer, Christian
    Jilma, Bernd
    Hengstenberg, Christian
    Siller-Matula, Jolanta M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S450 - S450
12345